Your browser doesn't support javascript.
loading
Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond.
Corren, Jonathan; Brightling, Christopher E; Boulet, Louis-Philippe; Porsbjerg, Celeste; Wechsler, Michael E; Menzies-Gow, Andrew; Ambrose, Christopher S; Cook, Bill; Martin, Neil; Spahn, Joseph; Llanos, Jean-Pierre.
Afiliação
  • Corren J; David Geffen School of Medicine, UCLA, Los Angeles, CA, USA jcorren@ucla.edu.
  • Brightling CE; Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Boulet LP; Québec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.
  • Porsbjerg C; Department of Respiratory Medicine, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Wechsler ME; National Jewish Health, Denver, CO, USA.
  • Menzies-Gow A; Royal Brompton and Harefield Hospitals, School of Immunology and Microbial Sciences, King's College, London, UK.
  • Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA.
  • Cook B; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA.
  • Martin N; Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Spahn J; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
  • Llanos JP; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA.
Eur Respir J ; 61(3)2023 03.
Article em En | MEDLINE | ID: mdl-36997233

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Doenças Cardiovasculares / Doença Pulmonar Obstrutiva Crônica Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Doenças Cardiovasculares / Doença Pulmonar Obstrutiva Crônica Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article